Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Hum Genet. 2013 Aug 8;58(10):679–685. doi: 10.1038/jhg.2013.78

Table 3.

Distributions of XRCC3 and XRCC4 diplotypes and haplotypes and their associations with non-small-cell lung cancer in Han population

Haplotype Frequency (%)
Diplotype Frequency (%)
Odds ratios
P-value
Case Control Case Control 95% confidence intervalsa
XRCC3 (rs861539–rs1799796–rs861537–rs1799794)(Ppermutation test = 0.001)
CAGG 38.6 45.3 CAGG/CAGG 20.3 27.3 1
CGAA 36.7 31.3 CAGG/CGAA 30.2 31.5 1.21 (0.84–1.74) 0.311
CAGA 14.5 12.2 CGAA/CGAA 15.4 10.4 1.93 (1.21–3.07) 0.006
TAAA 5.5 4.7 CAGA/CAGG 11.0 12.1 1.33 (0.82–2.15) 0.245
Othersb 4.7 6.5 CAGA/CGAA 13.6 10.0 1.82 (1.13–2.96) 0.015
CAGG/TAAA 5.7 3.5 2.07 (1.05–4.08) 0.036
CAGA/TAAA 1.4 1.1 3.11 (0.93–10.35) 0.065
Othersc 2.4 4.1 0.68 (0.30–1.54) 0.352
XRCC4 (rs3734091–rs1056503)(Ppermutation test = 0.013)
CG 70.8 66.8 CG/CG 49.1 44.1 1
CT 22.9 27.9 CG/CT 34.5 39.4 0.76 (0.56–1.02) 0.067
AG 4.5 3.3 CG/AG 6.9 4.6 1.39 (0.76–2.52) 0.285
AT 1.8 2.0 CT/CT 4.2 5.7 0.67 (0.35–1.27) 0.220
CG/AT 4.1 4.2 0.63 (0.33–1.21) 0.164
Others 1.2 2.0 1.10 (0.35–3.46) 0.876

Abbreviations: XRCC3, X-ray repair cross-complementing group 3; XRCC4, X-ray repair cross-complementing group 4.

Bold numerals: A P-value of <0.05 was considered statistically significant.

a

Adjusted by age, gender, education, family history of lung cancer, smoking status, environmental tobacco smoke, and mental and marital status.

b

Frequency <5%.

c

Frequency <2%.